Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Synthesis of chiral cyclobutanes via rhodium/diene-catalyzed asymmetric 1,4-addition: a dramatic ligand effect on the diastereoselectivity

Ya-Jing Chen , Tian-Jiao Hu , Chen-Guo Feng * and Guo-Qiang Lin
CAS Key Laboratory of Synthetic Chemistry of Natural Substances, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, P. R. China. E-mail: fengcg@sioc.ac.cn; Fax: +86 21 5080 7388; Tel: +86 21 5492 5081

Received 10th March 2015 , Accepted 16th April 2015

First published on 17th April 2015


Abstract

A highly diastereo- and enantioselective rhodium-catalyzed arylation of cyclobutenes for the efficient synthesis of chiral cyclobutanes has been developed. Chiral diene ligands exhibited excellent capability for the reaction diastereoselectivity control.


Chiral cyclobutanes exist as core subunits in numerous natural products1,2 and pharmaceutical agents.3 Moreover, a number of interesting chemical transformations associated with the four-membered strained ring render them valuable building blocks for organic synthesis.4 As a result, significant efforts have been directed to the asymmetric construction of chiral cyclobutane rings,5 and some catalytic asymmetric methods have been developed during the past decades, including asymmetric organo-6 or Lewis acid-catalyzed [2+2] cycloaddition,7 asymmetric ring expansion of cyclopropanes,8 asymmetric intramolecular ring closure of linear substrates9 and asymmetric functionalization of prochiral cyclobutane derivatives.10–12 The last strategy can avoid the relatively difficult construction of the constrained ring. More importantly, it provides a diverse synthetic approach using different functionalization reactions and easily accessible cyclobutanes as starting materials. To the best of our knowledge, almost all the present successful examples are limited to the chemical modifications of cyclobutanone substrates (Scheme 1, eqn (1)).10 Very recently, Yu and co-workers reported the asymmetric C–H activation/arylation of cyclobutane rings (eqn (2)).11 Maulide and co-workers reported the palladium-catalyzed allylic alkylation of 4-chlorocyclobut-2-enecarboxylic acid (eqn (3)).12 We envisioned that the well-established asymmetric rhodium-catalyzed addition of organometallic reagents to electron deficient double bonds could lead to a straightforward and diverse access to chiral cyclobutanes.13 Although five- and six-membered counterparts are among the most tested substrates in rhodium-catalyzed 1,4-additions, only a single non-asymmetric example of the addition to cyclobutene was introduced by Tang and co-workers14 in their synthesis toward pipercyclobutanamide A and piperchabamide G and its asymmetric version remains unreported.
image file: c5cc02023a-s1.tif
Scheme 1 Asymmetric functionalization of cyclobutane derivatives.

We reason that cyclobutene-1-carboxylate esters are suitable precursors for the enantioselective synthesis of chiral cyclobutanes, which can be easily prepared via three steps from widely available ethyl cyclobutanecarboxylate,15 and the ester groups could serve as a handle for further functionalization. However, it would be challenging to control both stereogenic centers generated in the addition process with such substrates. Especially, upon the first enantioselective addition at the β-position, the subsequent protonation of the resulting oxa-π-allylrhodium intermediate would generate a second chiral center, which is usually quite difficult to control unless the α-substituent can induce a different protonation pathway in the reported similar examples.16 Herein, we report our research on the ligand enabled highly diastereo- and enantioselective rhodium-catalyzed arylation of cyclobutene-1-carboxylate esters for the efficient synthesis of chiral cyclobutanes.

First, we tested the addition of phenylboronic acid to the ethyl ester substrate (1a) in the presence of the active hydroxo rhodium complex [Rh(OH)(L1)].17 Gratifyingly, the reaction took place smoothly, affording the desired product in 61% yield with high diastereoselectivity despite low enantioselectivity. It was reported that the ester substituents could affect the stereoselectivity control for the aryl addition to linear α,β-unsaturated ester systems,18 thus a variety of different esters were examined in our case (Table 1). Although more sterically hindered substituents clearly improved the enantioselectivity, the reaction yield and diastereoselectivity were highly dependent on the structure pattern of substituents. The 2,6-diphenylphenyl substituent provided the highest enantioselectivity and maintained high diastereoselectivity, but a reduced reaction yield (entry 8).

Table 1 Rhodium-catalyzed 1,4-addition of phenylboronic acid to cyclobutene-1-carboxylates: effect of ester groupsa

image file: c5cc02023a-u1.tif

Entry Substrate (R) Yieldb (%) trans/cisc trans-3 ee of 3d (%)
a Reactions were carried out with 1 (0.1 mmol), 2a (0.2 mmol), [Rh(OH)(L1)]2 (0.0015 mmol), 2.0 M aq. KOH (0.2 mmol) in toluene (1 mL) at 50 °C for 5 h. b A combined isolated yield of 3 and 4. c Determined by GC analysis. d Determined by chiral HPLC analysis.
1 1a (Et) 61 13/1 3aa 21
2 1b (iPr) 50 12/1 3ba 24
3 1c (tBu) 50 5/1 3ca 74
4 1d (Bn) 21 12/1 3da 9
5 1e (Ph) 25 15/1 3ea 74
6 1f (2,6-Me2C6H3) 80 2.6/1 3fa 87
7 1g (2,6-iPr2C6H3) 99 2.1/1 3ga 89
8 1h (2,6-Ph2C6H3) 35 12/1 3ha 92


Next, we turned to investigate this reaction using an in situ generated chiral rhodium catalyst. With ester 1h as a substrate and [RhCl(C2H4)2]2 as a precatalyst, a variety of chiral ligands were examined (Table 2).19 A significantly improved yield was obtained from the same ligand L1 (entry 1 vs.Table 1, entry 8). However, attempts to further increase the enantioselectivity of this reaction by introducing different substituents to the phenyl ring of ligand L1 were unsuccessful. It is worth mentioning that the diastereoselectivity was significantly improved by the introduction of electron-withdrawing substituents (entries 2–9). The highest diastereoselectivity was achieved using para 4-CF3O substituted ligand L8, albeit with a slight loss in reaction yield, which was brought back by a lower temperature and a prolonged reaction time (entries 8 and 9). Bicyclo[2.2.2]octadiene L920 gave a similar reaction yield and diastereoselectivity compared with L1, but with lower enantioselectivity (entry 10). All the tested phosphine-containing ligands failed to promote this reaction effectively and only a trace amount of the product was generated in most cases under current reaction conditions (entries 11–17). Interestingly, while bisphosphine ligands gave low diastereoselectivities, relatively electron-deficient phosphoramidite ligands showed much higher diastereoselectivities, consistent with the trend observed for diene ligands. The high diastereoselectivity control by electron-deficient ligands may be attributed to the quick protonation of the carbon–rhodium bond, which was generated after the cis addition of the aryl rhodium species to the olefin. The stereochemically retentive direct protonation step could prevent the uncontrollable oxa-π-allylrhodium protonation pathway,21 thus the addition reaction led to the trans product.

Table 2 Rhodium-catalyzed 1,4-addition of phenylboronic acid to cyclobutene-1-carboxylate 1h: the effect of chiral ligandsa

image file: c5cc02023a-u2.tif

Entry Ligand Yieldb (%) trans/cisc ee of 3had (%)
a Reactions were carried out with 1h (0.1 mmol), 2a (0.2 mmol), [Rh(C2H4)2Cl]2 (0.0015 mmol), L (0.0033 mmol), 2.0 M aq. KOH (0.2 mmol) in toluene (1 mL) at 50 °C for 5 h unless otherwise noted. b A combined yield of 3ha and 4ha, which was determined by GC using dodecane as an internal standard. c Determined by GC. d Determined by chiral HPLC analysis. e Reaction was made to run at 30 °C for 24 h.
1 L1 (R = H) 97 15/1 92
2 L2 (R = 4-MeO) 77 11/1 89
3 L3 (R = 3,5-Me2) 73 9/1 93
4 L4 (R = 3,5-MeO2) 74 10/1 91
5 L5 (R = 4-F) 88 20/1 88
6 L6 (R = 4-CF3) 80 40/1 92
7 L7 (R = 3,5-F2) 75 47/1 92
8 L8 (R = 4-OCF3) 72 52/1 92
9e L8 (R = 4-OCF3) 99 62/1 92
10 L9 86 14/1 74
11 L10 8 2.2/1
12 L11 4 1.5/1
13 L12 1 1.6/1
14 L13 21 1.3/1 96
15 L14 5 1.5/1
16 L15 18 8/1 25
17 L16 3 25/1


With optimal reaction conditions identified (Table 2, entry 9), a wide range of arylboronic acids were explored as depicted in Table 3. Excellent diastereoselectivities were obtained for all the tested arylboronic acids although the reaction yields were affected by both steric and electronic properties of aryl groups. In general, electron-donating groups at the para position of the phenyl ring would benefit the reaction yields, and the sterically hindered ortho-substituted arylboronic acid gave only moderate reaction yield even at elevated reaction temperature. As for the enantioselectivity, the reactions with most arylboronic acids provided good to excellent ees (83–98%). The absolute configuration of product 3hh was ambiguously determined by a single-crystal X-ray analysis as depicted in Scheme 2,22 and other products were assigned by analogy.

Table 3 Rhodium-catalyzed 1,4-addition of arylboronic acid to cyclobutene-1-carboxylate 1ha

image file: c5cc02023a-u3.tif

Entry Ar trans-3 Yieldb (%) trans/cisc eed (%)
a Reactions were carried out with 1h (0.2 mmol), 2 (0.4 mmol), [Rh(C2H4)2Cl]2 (0.003 mmol), L8 (0.0066 mmol), 2.0 M aq. KOH (0.4 mmol) in toluene (2 mL) at 30 °C for 24 h unless otherwise noted. b Isolated yield. c Determined by GC. d Determined by chiral HPLC analysis. e 50 °C.
1 Ph (2a) 3ha 99 62/1 92
2 4-MeOC6H4 (2b) 3hb 90 99/1 89
3 4-tBuC6H4 (2c) 3hc 97 49/1 93
4 4-CF3C6H4 (2d) 3hd 73 32/1 98
5e 4-CO2MeC6H4 (2e) 3he 36 >99/1 92
6 4-FC6H4 (2f) 3hf 78 32/1 97
7 4-ClC6H4 (2g) 3hg 96 49/1 97
8 4-BrC6H4 (2h) 3hh 92 49/1 96
9 3-MeOC6H4 (2i) 3hi 91 >99/1 93
10 3-FC6H4 (2j) 3hj 84 49/1 97
11 3-CO2MeC6H4 (2k) 3hk 95 32/1 96
12e 2-MeO (2l) 3hl 51 16/1 96
13 1-Naphthyl (2m) 3hm 96 >99/1 83
14 2-Naphthyl (2n) 3hn 68 >99/1 87



image file: c5cc02023a-s2.tif
Scheme 2 The X-ray diffraction structure of 3hh.

The obtained products can be easily converted to other cyclobutane derivatives. As shown in Scheme 3, reduction of ester 3ha with LiAlH4 at room temperature furnished alcohol 5 in 97% yield. The hydrolysis could provide acid 6 in 89% yield. Treatment of ester 3ha with lithium diisopropylamide (LDA) followed by alkylation with allyl iodide afforded product 7 as a single diastereomer with a negligible loss in optical purity.


image file: c5cc02023a-s3.tif
Scheme 3 Transformations of product 3ha.

In summary, we have developed a highly diastereo- and enantioselective rhodium-catalyzed arylation of cyclobutene-1-carboxylate esters, which provides an efficient synthetic approach for chiral butanes. Chiral diene ligands, especially electron deficient ones, exhibited excellent diastereoselectivity control. In addition, the versatile transformations of the product warrant the synthetic utility of this methodology.

This work was generously supported by the National Natural Science Foundation of China (21472212), the Shanghai Municipal Committee of Science and Technology (14ZR1448500) and the Collaborative Innovation Center of Chemical Science and Engineering (Tianjing). We acknowledge Dr Han-Qing Dong for his help in the preparation of this manuscript.

Notes and references

  1. For review: V. M. Dembitsky, J. Nat. Med., 2008, 62, 1–33 CrossRef CAS PubMed.
  2. For selected examples: (a) P. S. Baran, D. P. O'Malley and A. L. Zografos, Angew. Chem., Int. Ed., 2004, 43, 2674–2677 CrossRef CAS PubMed; (b) H. Ito, M. Hasegawa, Y. Takenaka, T. Kobayashi and K. Iguchi, J. Am. Chem. Soc., 2004, 126, 4520–4521 CrossRef CAS PubMed; (c) K. Takao, N. Hayakawa, R. Yamada, T. Yamaguchi, H. Saegusa, M. Uchida, S. Samejima and K. Tadano, J. Org. Chem., 2009, 74, 6452–6461 CrossRef CAS PubMed.
  3. For selected examples: (a) J. Singh, G. S. Bisacchi, S. Ahmad, J. D. Godfrey, Jr., T. P. Kissick, T. Mitt, O. Kocy, T. Vu, C. G. Papaioannou, M. K. Wong, J. E. Heikes, R. Zahler and R. H. Mueller, Org. Process Res. Dev., 1998, 2, 393–399 CrossRef CAS; (b) P. Maity and B. König, Biopolymers, 2008, 90, 8–27 CrossRef CAS PubMed.
  4. For review: (a) J. C. Namyslo and D. E. Kaufmann, Chem. Rev., 2003, 103, 1485–1537 CrossRef CAS PubMed; (b) T. Seiser, T. Saget, D. N. Tran and N. Cramer, Angew. Chem., Int. Ed., 2011, 50, 7740–7752 CrossRef CAS PubMed.
  5. For review: E. Lee-Ruff and G. Mladenova, Chem. Rev., 2003, 103, 1449–1483 CrossRef CAS PubMed.
  6. (a) K. Ishihara and K. Nakano, J. Am. Chem. Soc., 2007, 129, 8930–8931 CrossRef CAS PubMed; (b) G. Talavera, E. Reyes, J. L. Vicario and L. Carrillo, Angew. Chem., Int. Ed., 2012, 51, 4104–4107 CrossRef CAS PubMed; (c) G.-J. Duan, J.-B. Ling, W.-P. Wang, Y.-C. Luo and P.-F. Xu, Chem. Commun., 2013, 49, 4625–4627 RSC.
  7. (a) T. A. Engler, M. A. Letavic, R. Iyengar, K. O. LaTessa and J. P. Reddy, J. Org. Chem., 1999, 64, 2391–2405 CrossRef CAS; (b) E. Canales and E. J. Corey, J. Am. Chem. Soc., 2007, 129, 12686–12687 CrossRef CAS PubMed; (c) S. Suárez-Pantiga, C. Hernández-Díaz, E. Rubio and J. M. Gonzalez, Angew. Chem., Int. Ed., 2012, 51, 11552–11555 CrossRef PubMed.
  8. F. Kleinbeck and F. D. Toste, J. Am. Chem. Soc., 2009, 131, 9178–9179 CrossRef CAS PubMed.
  9. (a) R. Panish, S. R. Chintala, D. T. Boruta, Y. Z. Fang, M. T. Taylor and J. M. Fox, J. Am. Chem. Soc., 2013, 135, 9283–9286 CrossRef CAS PubMed; (b) Y. X. Liu, Y. Liu, C. S. Shanahan, X. Xu and M. P. Doyle, Org. Biomol. Chem., 2014, 12, 5227–5234 RSC.
  10. (a) M. Lopp, A. Paju, T. Kanger and T. Pehk, Tetrahedron Lett., 1996, 37, 7583–7586 CrossRef CAS; (b) D. Hazelard and A. Fadel, Tetrahedron: Asymmetry, 2005, 16, 2067–2070 CrossRef CAS PubMed; (c) D. Mailhol, M. M. Sanchez Duque, W. Raimondi, D. Bonne, T. Constantieux, Y. Coquerel and J. Rodriguez, Adv. Synth. Catal., 2012, 354, 3523–3532 CrossRef CAS PubMed; (d) D. J. Aitken, P. Caboni, H. Eijsberg, A. Frongia, R. Guillot, J. Ollivier, P. P. Piras and F. Secci, Adv. Synth. Catal., 2014, 356, 941–945 CrossRef CAS PubMed; (e) C. M. Reeves, C. Eidamshaus, J. Kim and B. M. Stoltz, Angew. Chem., Int. Ed., 2013, 52, 6718–6721 CrossRef CAS PubMed.
  11. K.-J. Xiao, D. W. Lin, M. Miura, R.-Y. Zhu, W. Gong, M. Wasa and J.-Q. Yu, J. Am. Chem. Soc., 2014, 136, 8138–8142 CrossRef CAS PubMed.
  12. A. Misale, S. Niyomchon, M. Luparia and N. Maulide, Angew. Chem., Int. Ed., 2014, 53, 7068–7073 CrossRef CAS PubMed.
  13. For leading reviews on Rh-catalyzed asymmetric conjugated additions: (a) T. Hayashi and K. Yamasaki, Chem. Rev., 2003, 103, 2829–2844 CrossRef CAS PubMed; (b) C. Gennari, C. Monti and U. Piarulli, Pure Appl. Chem., 2006, 78, 303–310 CrossRef CAS; (c) J. Christoffers, G. Koripelly, A. Rosiak and M. Röessle, Synthesis, 2007, 1279–1300 CrossRef CAS PubMed; (d) H. J. Edwards, J. D. Hargrave, S. D. Penrose and C. G. Frost, Chem. Soc. Rev., 2010, 39, 2093–2105 RSC.
  14. R. Liu, M. Zhang, T. P. Wyche, G. N. Winston-McPherson, T. S. Bugni and W. Tang, Angew. Chem., Int. Ed., 2012, 51, 7503–7506 CrossRef CAS PubMed.
  15. (a) A. Campbell and H. N. Rydon, J. Chem. Soc., 1953, 3002–3008 RSC; (b) J. C. Lee, K. A. Parker and N. S. Sampson, J. Am. Chem. Soc., 2006, 128, 4578–4579 CrossRef CAS PubMed; (c) M. E. Jung and G. Deng, J. Org. Chem., 2012, 77, 11002–11005 CrossRef CAS PubMed.
  16. (a) T. Hayashi, T. Senda and M. Ogasawara, J. Am. Chem. Soc., 2000, 122, 10716–10717 CrossRef CAS; (b) L. Navarre, S. Darses and J.-P. Genet, Angew. Chem., Int. Ed., 2004, 43, 719–723 CrossRef CAS PubMed; (c) R. J. Moss, K. J. Wadsworth, C. J. Chapman and C. G. Frost, Chem. Commun., 2004, 1984–1985 RSC; (d) L. Navarre, R. Martinez, J.-P. Genet and S. Darses, J. Am. Chem. Soc., 2008, 130, 6159–6169 CrossRef CAS PubMed; (e) X. Zhang, G. Chen, P. Cao, J. Liu and J. Liao, Tetrahedron Lett., 2012, 53, 438–441 CrossRef CAS PubMed.
  17. (a) Z.-Q. Wang, C.-G. Feng, M.-H. Xu and G.-Q. Lin, J. Am. Chem. Soc., 2007, 129, 5336–5337 CrossRef CAS PubMed; (b) S. Helbig, S. Sauer, N. Cramer, S. Laschat, A. Baro and W. Frey, Adv. Synth. Catal., 2007, 349, 2331–2337 CrossRef CAS PubMed; (c) Z. Cui, H.-J. Yu, R.-F. Yang, W.-Y. Gao, C.-G. Feng and G.-Q. Lin, J. Am. Chem. Soc., 2011, 133, 12394–12397 CrossRef CAS PubMed.
  18. (a) J.-F. Paquin, C. R. J. Stephenson, C. Defieber and E. M. Carreira, Org. Lett., 2005, 7, 3821–3824 CrossRef CAS PubMed; (b) T. Itoh, T. Mase, T. Nishikata, T. Iyama, H. Tachikawa, Y. Kobayashi, Y. Yamamoto and N. Miyaura, Tetrahedron, 2006, 62, 9610–9621 CrossRef CAS PubMed; (c) R. Shintani and T. Hayashi, Org. Lett., 2011, 13, 350–352 CrossRef CAS PubMed.
  19. Reviews of chiral olefin ligands: (a) C. Defieber, H. Grüetzmacher and E. M. Carreira, Angew. Chem., Int. Ed., 2008, 47, 4482–4502 CrossRef CAS PubMed; (b) J. B. Johnson and T. Rovis, Angew. Chem., Int. Ed., 2008, 47, 840–871 CrossRef CAS PubMed; (c) R. Shintani and T. Hayashi, Aldrichimica Acta, 2009, 42, 31–38 CAS; (d) C.-G. Feng, M.-H. Xu and G.-Q. Lin, Synlett, 2011, 1345–1356 CAS; (e) X. Feng and H. Du, Asian J. Org. Chem., 2012, 1, 204–213 CrossRef CAS PubMed.
  20. N. Tokunaga, Y. Otomaru, K. Okamoto, K. Ueyama, R. Shintani and T. Hayashi, J. Am. Chem. Soc., 2004, 126, 13584–13585 CrossRef CAS PubMed.
  21. C. M. So, S. Kume and T. Hayashi, J. Am. Chem. Soc., 2013, 135, 10990–10993 CrossRef CAS PubMed.
  22. CCDC 1042990 contains the supplementary crystallographic data for compound 3hh.

Footnote

Electronic supplementary information (ESI) available. CCDC 1042990. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5cc02023a

This journal is © The Royal Society of Chemistry 2015